Doliracetam

Nootropic

Doliracetam is retained as a catalog identity with independently verified primary-literature context. No qualified exposure model, dose recommendation, efficacy claim, or safety claim is provided.

Pharmacokinetic model

A route-level PK model for doliracetam is being prepared from published data. Dosing references, studies, and documented interactions are below; the app catalog is updated as models are validated.

Key facts

Category
Nootropic
Suggested cadence
once daily

Research behind this entry

  1. Broad spectrum and prolonged efficacy of dimiracetam in models of neuropathic pain. Fariello RG, Ghelardini C, Di Cesare Mannelli L, Bonanno G, Pittaluga A, Milanese M, Misiano P, Farina C · Neuropharmacology, 2014 DOI

    This citation reports a laboratory or cell study on a distinct analogue or compound class, not direct evidence for Doliracetam. No indexed doliracetam primary study was located; this study concerns the distinct racetam…

1 published study referenced in the app, each with a plain-language summary.